Wellington Management Group
XBI icon

Wellington Management Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wellington Management Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Buy
+121,769
New +$16.5M ﹤0.01% 1079
2025
Q2 		– Sell
-101,946
Closed -$8.27M – 2066
2025
Q1 		$8.27M Buy
101,946
+36,696
+56% +$3.28M ﹤0.01% 1248
2024
Q4 		$5.88M Buy
65,250
+12,689
+24% +$1.23M ﹤0.01% 1313
2024
Q3 		$5.19M Buy
52,561
+21,049
+67% +$2.07M ﹤0.01% 1323
2024
Q2 		$2.92M Hold
31,512
– – ﹤0.01% 1433
2024
Q1 		$2.99M Hold
31,512
– – ﹤0.01% 1441
2023
Q4 		$2.81M Hold
31,512
– – ﹤0.01% 1418
2023
Q3 		$2.3M Sell
31,512
-500
-2% -$39.9K ﹤0.01% 1448
2023
Q2 		$2.66M Sell
32,012
-2,100
-6% -$176K ﹤0.01% 1422
2023
Q1 		$2.6M Sell
34,112
-96,804
-74% -$8.03M ﹤0.01% 1449
2022
Q4 		$10.9M Buy
130,916
+102,204
+356% +$8.27M ﹤0.01% 1065
2022
Q3 		$2.28M Sell
28,712
-326,531
-92% -$27.5M ﹤0.01% 1495
2022
Q2 		$26.4M Buy
355,243
+286,644
+418% +$21.5M 0.01% 867
2022
Q1 		$6.17M Buy
68,599
+38,499
+128% +$3.56M ﹤0.01% 1338
2021
Q4 		$3.37M Sell
30,100
-240,400
-89% -$29M ﹤0.01% 1560
2021
Q3 		$34M Sell
270,500
-8,691
-3% -$1.12M 0.01% 931
2021
Q2 		$37.8M Sell
279,191
-667,385
-71% -$87.7M 0.01% 913
2021
Q1 		$128M Buy
946,576
+930,976
+5,968% +$139M 0.02% 535
2020
Q4 		$2.2M Buy
15,600
+6,500
+71% +$833K ﹤0.01% 1475
2020
Q3 		$1.01M Buy
9,100
+3,700
+69% +$415K ﹤0.01% 1549
2020
Q2 		$605K Buy
+5,400
New +$532K ﹤0.01% 1606
2017
Q1 		– Sell
-10,000
Closed -$592K – 2322
2016
Q4 		$592K Buy
+10,000
New +$617K ﹤0.01% 1973

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Wellington Management Group's XBI Position: Q2 2026 in Review

Wellington Management Group opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 121,769 shares worth $19.3M. The stake represents ﹤0.01% of the portfolio and ranks #1079 among its holdings. This is a return to the name: Wellington Management Group previously reported a position in XBI as recently as Q1 2025.

Wellington Management Group first reported a position in XBI in Q4 2016 and has held it in 22 quarters since. The position peaked at $128M in Q1 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Wellington Management Group held 121,769 shares of State Street SPDR S&P Biotech ETF worth $19.3M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Wellington Management Group position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1079 holding.
  • Wellington Management Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and has held it in 22 quarters since.
  • Wellington Management Group's State Street SPDR S&P Biotech ETF position peaked at $128M in Q1 2021.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.